Moreover, the same group showed that SIRD had a higher prevalence of the rs738409 (G) polymorphism of the patatin-like phospholipase domain-containing 3 (PNPLA3) gene, which is associated with increased risk and progression of NAFLD [35]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.